$Predicting imminent fractures in patients with a recent fracture or starting oral bisphosphonate therapy: development and international validation of prognostic models$

Predicting imminent fractures in patients with a recent fracture or starting oral bisphosphonate therapy: development and international validation of prognostic models

The availability of anti-osteoporosis medications with rapid onset and high potency requires tools to identify patients at high imminent fracture risk (IFR). There are few tools that predict a patient's IFR. We aimed to develop and validate tools for target patients with a recent fracture or in...

Full description

Bibliographic Details
Main Authors:	Khalid, S, Pineda Moncusi, M, El‐Hussein, L, Delmestri, A, Ernst, M, Smith, C, Libanati, C, Toth, E, Javaid, MK, Cooper, C, Abrahamsen, B, Prieto‐Alhambra, D
Format:	Journal article
Language:	English
Published:	Wiley 2021

Similar Items

Estimating the incidence and key risk factors of cardiovascular disease in patients at high risk of imminent fracture using routinely collected real-world data from the UK
by: Pineda-Moncusí, M, et al.
Published: (2022)

Imminent fracture risk assessments in the UK FLS setting: implications and challenges
by: Pinedo-Villanueva, R, et al.
Published: (2019)

Imminent fracture risk amongst new users of oral bisphosphonates in actual practice settings: A multi-national European cohort study from Denmark, Spain, and the UK
by: Khalid, S, et al.
Published: (2019)

Imminent (1- and 2-year) fracture risk following a first (sentinel) fracture: a multinational European cohort study including over 700,000 participants from Denmark, Spain, and the UK
by: Khalid, S, et al.
Published: (2019)

One- and 2-year incidence of osteoporotic fracture: a multi-cohort observational study using routinely collected real-world data
by: Khalid, S, et al.
Published: (2021)

Secular trends in the initiation of therapy in secondary fracture prevention in Europe: a multi-national cohort study including data from Denmark, Catalonia, and the United Kingdom
by: Skjødt, MK, et al.
Published: (2020)

The treatment gap after major osteoporotic fractures in Denmark 2005-2014: a combined analysis including both prescription-based and hospital-administered anti-osteoporosis medications
by: Skjødt, MK, et al.
Published: (2021)

Increased fracture risk in women treated with aromatase inhibitors versus tamoxifen: Beneficial effect of bisphosphonates
by: Pineda-Moncusí, M, et al.
Published: (2019)

The national treatment gap in secondary fracture prevention in Denmark 2005-2014: individual patient data including both hospital administered and all prescribed anti osteoporosis medications
by: Skjødt, MK, et al.
Published: (2019)

Secular trends in the initiation of therapy in secondary fracture prevention: widening treatment gaps in Denmark and Spain
by: Prieto-Alhambra, D, et al.
Published: (2018)

Secular trends in the initiation of therapy in secondary fracture prevention in Europe: a mutli-national study including data from Denmark, Spain, and the UK
by: Khalid, S, et al.
Published: (2018)

Patients With atypical femur fractures have the same mortality as the background population--drug-dhanneling bias, bisphosphonate effects, and public health implications
by: Abrahamsen, B, et al.
Published: (2016)

Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study
by: Robinson, DE, et al.
Published: (2021)

Predictors of second fracture while on treatment with oral bisphosphonates: a multinational cohort study
by: Hawley, S, et al.
Published: (2014)

Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study
by: Robinson, DE, et al.
Published: (2021)

Negative control time window to identify residual confounding in comparative effectiveness study: An example of bisphosphonate use and risk of fracture
by: Robinson, D, et al.
Published: (2018)

GGPS1 mutation and atypical femoral fractures with bisphosphonates.
by: Roca-Ayats, N, et al.
Published: (2017)

Predictors of fracture while on treatment with oral bisphosphonates: a population-based cohort study.
by: Prieto-Alhambra, D, et al.
Published: (2014)

Fracture risk before and after total hip replacement in patients with osteoarthritis: potential benefits of bisphosphonate use.
by: Prieto-Alhambra, D, et al.
Published: (2011)

Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study
by: Shah, A, et al.
Published: (2016)

The association between calcium ± vitamin D supplementation and fracture risk among incident users of oral bisphosphonates: a population-based cohort study
by: Reyes, C, et al.
Published: (2015)

Anti-osteoporosis medication prescriptions and incidence of secondary fracture amongst hip fracture patients in England and Wales: an age stratified interrupted time series analysis
by: Hawley, S, et al.
Published: (2018)

Cost-effectiveness of orthogeriatric and fracture liaison service models of care for hip fracture patients: a population based study
by: Leal, J, et al.
Published: (2016)

Anti-osteoporosis medication prescriptions and incidence of subsequent fracture among primary hip fracture patients in England and Wales: an interrupted time-series analysis
by: Hawley, S, et al.
Published: (2016)

Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial.
by: Prieto-Alhambra, D, et al.
Published: (2014)

Bisphosphonate use and risk of post-operative fracture among patients undergoing a total knee replacement for knee osteoarthritis: A propensity score analysis
by: Prieto-Alhambra, D, et al.
Published: (2011)

Bisphosphonate use and risk of post-operative fracture among patients undergoing a total knee replacement for knee osteoarthritis: a propensity score analysis.
by: Prieto-Alhambra, D, et al.
Published: (2011)

Fracture during oral bisphosphonate therapy is associated with deteriorated bone material strength index
by: Nogués, X, et al.
Published: (2017)

Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose
by: Vestergaard, P, et al.
Published: (2013)

Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose.
by: Vestergaard, P, et al.
Published: (2013)

Fractures in users of antidepressants and anxiolytics and sedatives effects of age and dose
by: Vestergaard, P, et al.
Published: (2012)

Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures
by: Javaid, M, et al.
Published: (2019)

Two-fold regional variation in initiation of anti-osteoporosis medication after hip fracture in the UK
by: Shah, A, et al.
Published: (2016)

Two-fold regional variation in initiation of anti-osteoporosis medication after hip fracture in the UK
by: Shah, A, et al.
Published: (2016)

Bariatric surgery increases the rate of major fracture: self-controlled case series study in UK Clinical Practice Research Datalink
by: Robinson, DE, et al.
Published: (2021)

Oral bisphosphonate use and risk of acute kidney injury, gastrointestinal events and hypocalcaemia in patients with moderate-advanced chronic kidney disease: a population-based cohort study
by: Ali, MS, et al.
Published: (2017)

Subtrochanteric fracture in a Chinese woman with Paget's disease of bone and on long term bisphosphonate therapy: could it be An insufficiency fracture?
by: Lee, C.K., et al.
Published: (2011)

Clinical effectiveness of orthogeriatric and fracture liaison service models of care for hip fracture patients: population-based longitudinal study
by: Hawley, S, et al.
Published: (2016)

Bariatric surgery increases the risk of major osteoporotic fracture: a self-controlled case series patients from the CPRD GOLD database linked to HES
by: Robinson, DE, et al.
Published: (2019)

Review of the care home divide: secondary fracture prevention rates before admission with a hip fracture
by: Osborne, P, et al.
Published: (2018)